Related references
Note: Only part of the references are listed.The majority of endogenous microRNA targets within Alu elements avoid the microRNA machinery
Yonit Hoffman et al.
BIOINFORMATICS (2013)
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets
A. V. Antonov et al.
CELL DEATH AND DIFFERENTIATION (2013)
Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
Qin Li et al.
CLINICAL CANCER RESEARCH (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
The rebel angel: mutant p53 as the driving oncogene in breast cancer
Dawid Walerych et al.
CARCINOGENESIS (2012)
Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma
Koji Katada et al.
JOURNAL OF PROTEOMICS (2012)
Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis
Lior Golomb et al.
MOLECULAR CELL (2012)
Global MicroRNA Expression Profiling of High-Risk ER plus Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study
Maria B. Lyng et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
MicroRNAs in the p53 network: micromanagement of tumour suppression
Heiko Hermeking
NATURE REVIEWS CANCER (2012)
Plectin-1 as a Novel Biomarker for Pancreatic Cancer
Dirk Bausch et al.
CLINICAL CANCER RESEARCH (2011)
p53 and its mutants in tumor cell migration and invasion
Patricia A. J. Muller et al.
JOURNAL OF CELL BIOLOGY (2011)
Capture of MicroRNA-Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor Signaling
Ashish Lal et al.
PLOS GENETICS (2011)
Expression signatures of TP53 mutations in serous ovarian cancers
Marcus Q. Bernardini et al.
BMC CANCER (2010)
An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity
Jessika Wynendaele et al.
CANCER RESEARCH (2010)
The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1
Yael Aylon et al.
GENES & DEVELOPMENT (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
被撤回的出版物: miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers (Retracted article. See vol. 35, pg. 670, 2016)
G. Vetter et al.
ONCOGENE (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
MicroRNA-661, a c/EBPα Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions
Sirigiri Divijendra et al.
CANCER RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Isolation of microRNA targets using biotinylated synthetic microRNAs
Ulf Andersson Orom et al.
METHODS (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
LK Linares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
